Sanofi-Aventis U.S. LLC v. Par Pharmaceutical, Inc.

Application Number	Patent Number	External Links
-	US6794410	Espacenet Google Patents
-	US9186346	Espacenet Google Patents
-	US8802735	Espacenet Google Patents

COMPLAINT filed against Par Formulations Private Limited, Par Pharmaceutical Companies, Inc., Par Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2064201.) - filed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(jcs) (Entered: 01/13/2017)

2017-01-12

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 01/13/2017)

2017-01-12

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: December 1, 2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/12/2020. (jcs) (Entered: 01/13/2017)

2017-01-12

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 B2; US 8,802,735 B2. (jcs) (Entered: 01/13/2017)

2017-01-12

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Aventisub LLC, Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 01/13/2017)

2017-01-13

1

View

No Summons Issued. (jcs)

2017-01-13

1

No Actions

Summons Issued with Magistrate Consent Notice attached as to Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc. on 1/13/2017. (sar)

2017-01-13

1

No Actions

No Summons Issued

2017-01-13

1

No Actions

Summons Issued

2017-01-13

1

No Actions

SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Par Pharmaceutical, Inc. served on 1/16/2017, answer due 2/6/2017. (Bove, Jeffrey) (Entered: 01/17/2017)

2017-01-17

1

View

SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Par Pharmaceutical Companies, Inc. served on 1/16/2017, answer due 2/6/2017. (Bove, Jeffrey) (Entered: 01/17/2017)

2017-01-17

1

View

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-00024-GMS, 1:17-cv-00027-GMS, 1:17-cv-00031-GMS, 1:17-cv-00034-GMS, 1:17-cv-00039-GMS and 1:17-cv-00040-GMS (rjb)

2017-01-18

1

No Actions

STIPULATION TO EXTEND TIME to Respond to Complaint to March 6, 2017 - filed by Par Formulations Private Limited, Par Pharmaceutical Companies, Inc., Par Pharmaceutical, Inc.. (Fineman, Steven) (Entered: 02/03/2017)

2017-02-03

1

View

~Util - Set/Reset Answer Deadline AND SO ORDERED

2017-02-06

1

No Actions

SO ORDERED - re 8 STIPULATION TO EXTEND TIME to Respond to Complaint to March 6, 2017 filed by Par Pharmaceutical, Inc., Par Pharmaceutical Companies, Inc., Par Formulations Private Limited, Set/Reset Answer Deadlines: Par Formulations Private Limited answer due 3/6/2017; Par Pharmaceutical Companies, Inc. answer due 3/6/2017; Par Pharmaceutical, Inc. answer due 3/6/2017. Ordered by Judge Gregory M. Sleet on 2/6/2017. (mdb)

2017-02-06

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 02/21/2017)

2017-02-21

1

View

SO ORDERED - re (11 in 1:17-cv-00039-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:17-cv-00027-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:16-cv-01333-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:16-cv-01326-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:17-cv-00004-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (15 in 1:16-cv-01330-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (9 in 1:17-cv-00019-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (10 in 1:17-cv-00003-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:17-cv-00070-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (9 in 1:17-cv-00040-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC, (11 in 1:16-cv-01300-GMS) MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Ordered by Judge Gregory M. Sleet on 2/27/2017. Associated Cases: 1:17-cv-00003-GMS et al.(mdb)

2017-02-27

1

No Actions

STIPULATION of Dismissal by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 03/03/2017)

2017-03-03

1

View

SO ORDERED - re 10 Stipulation of Dismissal Without Prejudice filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Signed by Judge Gregory M. Sleet on 4/12/2017. Civil Case Terminated (mdb) (Entered: 04/12/2017)

2017-04-12

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) (Entered: 04/17/2017)

2017-04-17

1

View

Overview

Parties

Defendant

Par Formulations Private Limited

Represented By

Par Pharmaceutical Companies, Inc.

Represented By

Par Pharmaceutical, Inc.

Represented By

Plaintiff

Genzyme Corporation

Represented By

Sanofi

Represented By

Aventisub LLC

Represented By

Sanofi-Aventis U.S. LLC

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 01/13/2017)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: December 1, 2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/12/2020. (jcs) (Entered: 01/13/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 B2; US 8,802,735 B2. (jcs) (Entered: 01/13/2017)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Aventisub LLC, Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 01/13/2017)

No Summons Issued. (jcs)

Summons Issued with Magistrate Consent Notice attached as to Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc. on 1/13/2017. (sar)

No Summons Issued

Summons Issued

SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Par Pharmaceutical, Inc. served on 1/16/2017, answer due 2/6/2017. (Bove, Jeffrey) (Entered: 01/17/2017)

SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Par Pharmaceutical Companies, Inc. served on 1/16/2017, answer due 2/6/2017. (Bove, Jeffrey) (Entered: 01/17/2017)

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-00024-GMS, 1:17-cv-00027-GMS, 1:17-cv-00031-GMS, 1:17-cv-00034-GMS, 1:17-cv-00039-GMS and 1:17-cv-00040-GMS (rjb)

STIPULATION TO EXTEND TIME to Respond to Complaint to March 6, 2017 - filed by Par Formulations Private Limited, Par Pharmaceutical Companies, Inc., Par Pharmaceutical, Inc.. (Fineman, Steven) (Entered: 02/03/2017)

~Util - Set/Reset Answer Deadline AND SO ORDERED

MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 02/21/2017)

STIPULATION of Dismissal by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 03/03/2017)

SO ORDERED - re 10 Stipulation of Dismissal Without Prejudice filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Signed by Judge Gregory M. Sleet on 4/12/2017. Civil Case Terminated (mdb) (Entered: 04/12/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) (Entered: 04/17/2017)

Sanofi-Aventis U.S. LLC v. Par Pharmaceutical, Inc.

Overview

Parties

Defendant

Par Formulations Private Limited Follow

Represented By

Par Pharmaceutical Companies, Inc. Follow

Represented By

Par Pharmaceutical, Inc. Follow

Represented By

Plaintiff

Genzyme Corporation Follow

Represented By

Sanofi Follow

Represented By

Aventisub LLC Follow

Represented By

Sanofi-Aventis U.S. LLC Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 01/13/2017)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: December 1, 2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/12/2020. (jcs) (Entered: 01/13/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 B2; US 8,802,735 B2. (jcs) (Entered: 01/13/2017)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Aventisub LLC, Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 01/13/2017)

No Summons Issued. (jcs)

Summons Issued with Magistrate Consent Notice attached as to Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc. on 1/13/2017. (sar)

No Summons Issued

Summons Issued

SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Par Pharmaceutical, Inc. served on 1/16/2017, answer due 2/6/2017. (Bove, Jeffrey) (Entered: 01/17/2017)

SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Par Pharmaceutical Companies, Inc. served on 1/16/2017, answer due 2/6/2017. (Bove, Jeffrey) (Entered: 01/17/2017)

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-00024-GMS, 1:17-cv-00027-GMS, 1:17-cv-00031-GMS, 1:17-cv-00034-GMS, 1:17-cv-00039-GMS and 1:17-cv-00040-GMS (rjb)

STIPULATION TO EXTEND TIME to Respond to Complaint to March 6, 2017 - filed by Par Formulations Private Limited, Par Pharmaceutical Companies, Inc., Par Pharmaceutical, Inc.. (Fineman, Steven) (Entered: 02/03/2017)

~Util - Set/Reset Answer Deadline AND SO ORDERED

MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, and Brandon J. Kennedy - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 02/21/2017)

STIPULATION of Dismissal by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 03/03/2017)

SO ORDERED - re 10 Stipulation of Dismissal Without Prejudice filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Signed by Judge Gregory M. Sleet on 4/12/2017. ***Civil Case Terminated*** (mdb) (Entered: 04/12/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) (Entered: 04/17/2017)

Track Case Updates

Par Formulations Private Limited

Par Pharmaceutical Companies, Inc.

Par Pharmaceutical, Inc.

Genzyme Corporation

Sanofi

Aventisub LLC

Sanofi-Aventis U.S. LLC

SO ORDERED - re 10 Stipulation of Dismissal Without Prejudice filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Signed by Judge Gregory M. Sleet on 4/12/2017. Civil Case Terminated (mdb) (Entered: 04/12/2017)